Weight loss plus vitamin D reduce cancer-linked chronic inflammation
the ONA take:
According to a new study published online ahead of print in the journal Cancer Prevention Research, researchers at Fred Hutchinson Cancer Research Center in Seattle, Washington, have found that the addition of vitamin D supplementation to weight loss had a greater improvement in chronic inflammation compared with weight loss alone.
Chronic inflammation is known to contribute to the development and progression of some cancers, as well as other diseases.
For the study, researchers enrolled 218 healthy, overweight, postmenopausal women who had insufficient vitamin D levels. All participants participated in a diet and weight loss program and half were randomly assigned to receive vitamin D 2,000 IU daily for 1 year.
Results showed that women who lost 5 to 10% of their body weight and took vitamin D supplementation experienced the greatest reduction in chronic inflammation.
"We were quite surprised to see that vitamin D had an effect on an inflammation biomarker only among women who lost at least 5 percent of their baseline weight," Catherine Duggan, Ph.D., a principal staff scientist in the Public Health Sciences Division at Fred Hutchinson Cancer Research Center said. "That suggests vitamin D can augment the effect of weight loss on inflammation."
Addition of vitamin D supplementation to weight loss had a greater improvement in chronic inflammation.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
- Urine Drug Testing Policy Can Assist Opioid Treatment Decisions
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|